首页> 美国卫生研究院文献>Nucleic Acids Research >Infrared nanospectroscopic mapping of a single metaphase chromosome
【2h】

Infrared nanospectroscopic mapping of a single metaphase chromosome

机译:单个中期染色体的红外纳米光谱图

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The integrity of the chromatin structure is essential to every process occurring within eukaryotic nuclei. However, there are no reliable tools to decipher the molecular composition of metaphase chromosomes. Here, we have applied infrared nanospectroscopy (AFM-IR) to demonstrate molecular difference between eu- and heterochromatin and generate infrared maps of single metaphase chromosomes revealing detailed information on their molecular composition, with nanometric lateral spatial resolution. AFM-IR coupled with principal component analysis has confirmed that chromosome areas containing euchromatin and heterochromatin are distinguishable based on differences in the degree of methylation. AFM-IR distribution of eu- and heterochromatin was compared to standard fluorescent staining. We demonstrate the ability of our methodology to locate spatially the presence of anticancer drug sites in metaphase chromosomes and cellular nuclei. We show that the anticancer 'rule breaker' platinum compound [Pt[N(p-HC6F4)CH2]2py2] preferentially binds to heterochromatin, forming localized discrete foci due to condensation of DNA interacting with the drug. Given the importance of DNA methylation in the development of nearly all types of cancer, there is potential for infrared nanospectroscopy to be used to detect gene expression/suppression sites in the whole genome and to become an early screening tool for malignancy.
机译:染色质结构的完整性对于真核内发生的每个过程都是必不可少的。但是,没有可靠的工具来破译中期染色体的分子组成。在这里,我们已应用红外纳米光谱(AFM-IR)来证明eu-和异染色质之间的分子差异,并生成单个中期染色体的红外图谱,揭示了其分子组成的详细信息,并具有纳米级的横向空间分辨率。 AFM-IR与主成分分析相结合已确认,基于甲基化程度的差异,可区分包含常染色质和异染色质的染色体区域。将正常染色质和异染色质的AFM-IR分布与标准荧光染色进行比较。我们证明了我们的方法论能够在空间上定位中期染色体和细胞核中抗癌药物位点的存在。我们显示抗癌的“规则突破者”铂化合物[Pt [N(p-HC6F4)CH2] 2py2]优先结合异染色质,由于与药物相互作用的DNA的缩合形成局部离散的病灶。鉴于DNA甲基化在几乎所有类型的癌症发展中的重要性,红外纳米光谱技术有可能被用于检测整个基因组中的基因表达/抑制位点,并成为恶性肿瘤的早期筛查工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号